Podcast: Allogeneic cell therapies and the immune system

"We're in an exciting age: the tools and techniques we now have open up the field of cell therapy to different indications than what was possible 10 years ago"

To the layperson, cancer and the immune system don’t seem closely related – there’s stronger association with diseases like Crohns, or allergies, or organ rejection if people are looking at immune disease. How do those two topics intersect and are developers working on immune cells as therapies for immune diseases too?

In this podcast, Dr. Tracey Lodie, CSO at Quell Therapeutics, and our CCO Andy Holt share their thoughts on revolutionary cancer treatments in cell therapy derived from immune cells.

Listen to learn more about:

• Specific roles of different immune cells in combating diseases
• Autologous vs allogeneic therapies
• Cell therapies for cancer treatment and diseases